Fairmount Funds Management LLC 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-23 5:00 pm Purchase | 2026-06-18 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 6,808,789 9.990% | 43,815 (+0.65%) | Filing |
| 2026-03-27 5:30 pm Purchase | 2026-03-26 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 6,764,974 9.990% | 717,947 (+11.87%) | Filing |
| 2026-01-22 8:00 pm Purchase | 2026-01-22 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 6,047,027 9.990% | 270,146 (+4.68%) | Filing |
| 2025-10-14 7:11 pm Purchase | 2025-10-10 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 5,776,881 9.990% | 1,014,323 (+21.30%) | Filing |
| 2024-04-01 5:42 pm Sale | 2024-03-28 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 4,762,558 9.990% | -640,495 (-11.85%) | Filing |
| 2024-01-31 4:30 pm Purchase | 2024-01-29 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 5,403,053 9.990% | 1,496,851 (+38.32%) | Filing |
| 2023-07-21 4:31 pm Purchase | 2023-07-13 | 13D | APOGEE THERAPEUTICS INC APGE | Fairmount Funds Management LLC | 3,906,202 9.990% | 3,906,202 (New Position) | Filing |